Aquestive Therapeutics announced it received a Complete Response Letter (CRL) from the FDA regarding its New Drug Application (NDA) for Anaphylm (dibutepinephrine) Sublingual Film, a noninvasive ...
EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European UnionARS Pharma’s partner, ...
EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European Union ...
Aquestive Therapeutics said on Monday the U.S. FDA has declined to approve its oral drug for severe allergic reactions due to packaging issues, marking a setback to its efforts to enter the allergy ...
The Register on MSN
Autonomous cars, drones cheerfully obey prompt injection by road sign
AI vision systems can be very literal readers Indirect prompt injection occurs when a bot takes input data and interprets it ...
Ward 5 Coun. Matthew Scott and Ward 3's Angela Caputo want EpiPen auto-injectors to be as easily accessible as naloxone or ...
Research published in Clinical and Experimental Allergy journal demonstrates how NHS prescription data is helping to improve anaphylaxis management across England. Analysis of adrenaline auto-injector ...
Using same proprietary, patented technology, VIVI Med extends the product portfolio beyond injectable pens, opening access to broader patient populations, premium biologics, and institutional ...
Many young patients are being put at risk because they have been prescribed an adrenaline autoinjector device at too low a ...
SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect ...
Two new research papers show how NHS Business Services Authority (NHSBSA) prescription data is advancing clinical understanding of adrenaline auto-injector (AAI) prescribing patterns and informing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results